4//SEC Filing
SAVIENT PHARMACEUTICALS INC 4
Accession 0001230295-05-000123
CIK 0000722104operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 12:30 PM ET
Size
5.4 KB
Accession
0001230295-05-000123
Insider Transaction Report
Form 4
Gyenes Lawrence A
SVP, Chief Financial Officer
Transactions
- Award
Common Stock, $.01 par value per share
2005-06-01+8,950→ 53,350 total
Footnotes (1)
- [F1]These shares were issued pursuant to a restricted stock grant, which vests in full on June 1, 2006. Mr. Gyenes has paid to the Company the par value of these shares.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000722104
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 12:30 PM ET
- Size
- 5.4 KB